Position in BCYC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$116,598
-$61,315 QoQ
Shares Held
25,129
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. BCYC ranks #444 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in BCYC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $116,598 | 25,129 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $177,913 | 25,129 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $309,019 | 39,925 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $280,863 | 40,412 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $181,490 | 21,377 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $543,410 | 38,815 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $867,521 | 38,335 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $432,670 | 21,377 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $532,287 | 21,377 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $340,572 | 18,837 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $344,422 | 17,144 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $437,514 | 17,144 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $364,652 | 17,144 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $507,462 | 17,144 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $498,229 | 21,420 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $186,811 | 11,133 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $488,516 | 11,133 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $601,395 | 9,880 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $410,909 | 9,880 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $227,062 | 7,479 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||